-
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Welcome to Sonic US
- Thread starter anonymous
- Start date
-
- Tags
- None
So how did those changes work out for you? much more efficient now or are you now seeing the real problem.
good luck - the industry is extremely challenging with all the work force issues.
good luck - the industry is extremely challenging with all the work force issues.
the place continues to lose accounts and corporate has zero message for we the people of the lab. looks like consolidations are in the mix but you would never know because they are too smart and we are too stupid. not nice people here.
This place is clueless and it goes all the way to the very top
The ivory tower lives on. no clue!! and yet they feel the brains in the ivory tower are the only brains available on planet earth. consolidations with regional tc facilities on the way
as shortages and intelligence will be lacking
as shortages and intelligence will be lackingagree on consolidation. labs will be shut down, is it mine????